{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:29:21Z","timestamp":1761848961875,"version":"build-2065373602"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04563-6","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:25:23Z","timestamp":1748348723000},"page":"4095-4104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The current clinical management of muscle wasting in hemodialysis patients with end-stage renal disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Shiyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"5","key":"4563_CR1","first-page":"493","volume":"104","author":"N Wouk","year":"2021","unstructured":"Wouk N (2021) End-stage renal disease: medical management. Am Fam Physician 104(5):493\u2013499","journal-title":"Am Fam Physician"},{"issue":"14","key":"4563_CR2","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3390\/nu15143107","volume":"15","author":"G Massini","year":"2023","unstructured":"Massini G, Caldiroli L, Molinari P et al (2023) Nutritional strategies to prevent muscle loss and sarcopenia in chronic kidney disease: what do we currently know? Nutrients 15(14):3107","journal-title":"Nutrients"},{"key":"4563_CR3","first-page":"26","volume":"509","author":"MM Braun","year":"2021","unstructured":"Braun MM, Khayat M (2021) Kidney disease: end-stage renal disease. FP Essent 509:26\u201332","journal-title":"FP Essent"},{"issue":"9","key":"4563_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W et al (2016) Trends in chronic kidney disease in China. N Engl J Med 375(9):905\u2013906","journal-title":"N Engl J Med"},{"key":"4563_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000527953","volume":"200","author":"C Ronco","year":"2023","unstructured":"Ronco C (2023) Combined hemoperfusion-hemodialysis in end-stage renal disease patients. Contrib Nephrol 200:118\u2013122","journal-title":"Contrib Nephrol"},{"issue":"3","key":"4563_CR6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/0886022X.2015.1132173","volume":"38","author":"H Ren","year":"2016","unstructured":"Ren H, Gong D, Jia F et al (2016) Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail 38(3):364\u2013371","journal-title":"Ren Fail"},{"issue":"9","key":"4563_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10(9):504\u2013516","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4563_CR8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00223-020-00782-4","volume":"108","author":"DV Leal","year":"2021","unstructured":"Leal DV, Ferreira A, Watson EL et al (2021) Muscle-bone crosstalk in chronic kidney disease: the potential modulatory effects of exercise. Calcif Tissue Int 108(4):461\u2013475","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"4563_CR9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.clnu.2018.05.004","volume":"38","author":"A Sabatino","year":"2019","unstructured":"Sabatino A, Regolisti G, Delsante M et al (2019) Noninvasive evaluation of muscle mass by ultrasonography of quadriceps femoris muscle in end-stage renal disease patients on hemodialysis. Clin Nutr 38(3):1232\u20131239","journal-title":"Clin Nutr"},{"issue":"9","key":"4563_CR10","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gft070","volume":"29","author":"IH Fahal","year":"2014","unstructured":"Fahal IH (2014) Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant 29(9):1655\u20131665","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"4563_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/j.jrn.2015.06.006","volume":"26","author":"MG Olvera-Soto","year":"2016","unstructured":"Olvera-Soto MG, Valdez-Ortiz R, L\u00f3pez Alvarenga J et al (2016) Effect of resistance exercises on the indicators of muscle reserves and handgrip strength in adult patients on hemodialysis. J Ren Nutr 26(1):53\u201360","journal-title":"J Ren Nutr"},{"issue":"2","key":"4563_CR12","doi-asserted-by":"crossref","first-page":"R337","DOI":"10.1152\/ajpregu.00469.2004","volume":"288","author":"SK Powers","year":"2005","unstructured":"Powers SK, Kavazis AN, DeRuisseau KC (2005) Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 288(2):R337\u2013R344","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"02","key":"4563_CR13","first-page":"181","volume":"24","author":"R Hongqi","year":"2015","unstructured":"Hongqi R, Dehua G (2015) The pathogensis and treatment of uraemic sarcopenia[J]. J Nephrol Dial Kidney Transpl 24(02):181\u2013185","journal-title":"J Nephrol Dial Kidney Transpl"},{"issue":"6","key":"4563_CR14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1474-9726.2011.00734.x","volume":"10","author":"S Sriram","year":"2011","unstructured":"Sriram S, Subramanian S, Sathiakumar D et al (2011) Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-\u03baB. Aging Cell 10(6):931\u2013948","journal-title":"Aging Cell"},{"issue":"8","key":"4563_CR15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm.3213","volume":"19","author":"E Woldt","year":"2013","unstructured":"Woldt E, Sebti Y, Solt LA et al (2013) Rev-erb-\u03b1 modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med 19(8):1039\u20131046","journal-title":"Nat Med"},{"issue":"15","key":"4563_CR16","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.3390\/ijms22158179","volume":"22","author":"JP Leduc-Gaudet","year":"2021","unstructured":"Leduc-Gaudet JP, Hussain SNA, Barreiro E et al (2021) Mitochondrial dynamics and mitophagy in skeletal muscle health and aging. Int J Mol Sci 22(15):8179","journal-title":"Int J Mol Sci"},{"key":"4563_CR17","unstructured":"(2016) Retraction for Wenz et al., Increased muscle PGC-1\u03b1 expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 113(52):E8502"},{"key":"4563_CR18","doi-asserted-by":"crossref","unstructured":"Thome T, Kumar RA, Burke SK et al (2020) Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease. JCI Insight 6(1)","DOI":"10.1172\/jci.insight.139826"},{"issue":"4","key":"4563_CR19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","volume":"83","author":"H Watanabe","year":"2013","unstructured":"Watanabe H, Miyamoto Y, Honda D et al (2013) p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83(4):582\u2013592","journal-title":"Kidney Int"},{"issue":"2","key":"4563_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.23876\/j.krcp.23.094","volume":"43","author":"RH Cha","year":"2024","unstructured":"Cha RH (2024) Pharmacologic therapeutics in sarcopenia with chronic kidney disease. Kidney Res Clin Pract 43(2):143\u2013155","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"4563_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249\u2013256","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"4563_CR22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","volume":"20","author":"L Zhang","year":"2009","unstructured":"Zhang L, Du J, Hu Z et al (2009) IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol 20(3):604\u2013612","journal-title":"J Am Soc Nephrol"},{"key":"4563_CR23","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1038\/srep14453","volume":"5","author":"C Yabumoto","year":"2015","unstructured":"Yabumoto C, Akazawa H, Yamamoto R et al (2015) Angiotensin II receptor blockade promotes repair of skeletal muscle through down-regulation of aging-promoting C1q expression. Sci Rep 5:14453","journal-title":"Sci Rep"},{"key":"4563_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.pharmtox.051208.165340","volume":"49","author":"AL Schwartz","year":"2009","unstructured":"Schwartz AL, Ciechanover A (2009) Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu Rev Pharmacol Toxicol 49:73\u201396","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"4563_CR25","doi-asserted-by":"crossref","first-page":"F1128","DOI":"10.1152\/ajprenal.00600.2016","volume":"312","author":"Z Su","year":"2017","unstructured":"Su Z, Klein JD, Du J et al (2017) Chronic kidney disease induces autophagy leading to dysfunction of mitochondria in skeletal muscle. Am J Physiol Renal Physiol 312(6):F1128\u2013F1140","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"4563_CR26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","volume":"18","author":"L Zhang","year":"2013","unstructured":"Zhang L, Pan J, Dong Y et al (2013) Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass. Cell Metab 18(3):368\u2013379","journal-title":"Cell Metab"},{"issue":"11","key":"4563_CR27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/gerona\/glq118","volume":"65","author":"RA Atkinson","year":"2010","unstructured":"Atkinson RA, Srinivas-Shankar U, Roberts SA et al (2010) Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men. J Gerontol A Biol Sci Med Sci 65(11):1215\u20131219","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"4563_CR28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/ajcn\/82.6.1235","volume":"82","author":"LB Pupim","year":"2005","unstructured":"Pupim LB, Flakoll PJ, Yu C et al (2005) Recombinant human growth hormone improves muscle amino acid uptake and whole-body protein metabolism in chronic hemodialysis patients. Am J Clin Nutr 82(6):1235\u20131243","journal-title":"Am J Clin Nutr"},{"key":"4563_CR29","unstructured":"Shinsuke K, Yuichi H, Hiroko S et al (2012) Muscle atrophy in patients wirh ckd results from fgf23\/klotho-mediated supression of insulin\/igf-i signaling. Kidney Res Clin Pract"},{"issue":"19","key":"4563_CR30","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.3390\/nu14194077","volume":"14","author":"W Wathanavasin","year":"2022","unstructured":"Wathanavasin W, Banjongjit A, Avihingsanon Y et al (2022) Prevalence of sarcopenia and its impact on cardiovascular events and mortality among dialysis patients: a systematic review and meta-analysis. Nutrients 14(19):4077","journal-title":"Nutrients"},{"issue":"3","key":"4563_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/sdi.13106","volume":"36","author":"MA Baltac\u0131","year":"2023","unstructured":"Baltac\u0131 MA, Atmis V, Metin Y et al (2023) Sarcopenia and cardiovascular risk indices: its impact on cardiovascular events and mortality in dialysis patients. Semin Dial 36(3):221\u2013230","journal-title":"Semin Dial"},{"key":"4563_CR32","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.721941","volume":"8","author":"C Macedo","year":"2021","unstructured":"Macedo C, Amaral TF, Rodrigues J et al (2021) Malnutrition and sarcopenia combined increases the risk for mortality in older adults on hemodialysis. Front Nutr 8:721941","journal-title":"Front Nutr"},{"issue":"07","key":"4563_CR33","first-page":"521","volume":"21","author":"F L\u00fcgui","year":"2022","unstructured":"L\u00fcgui F, Mingyang X, Yating D et al (2022) Research progress on the relationship between uremic toxin and chronic kidney disease sarcopenia. China Blood Purif 21(07):521\u2013524","journal-title":"China Blood Purif"},{"issue":"3","key":"4563_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1900\/RDS.2022.18.157","volume":"18","author":"D Purnamasari","year":"2022","unstructured":"Purnamasari D, Tetrasiwi EN, Kartiko GJ et al (2022) Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev Diabet Stud 18(3):157\u2013165","journal-title":"Rev Diabet Stud"},{"key":"4563_CR35","volume":"10","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang L, Hu Y et al (2022) Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis. PeerJ 10:e14429","journal-title":"PeerJ"},{"key":"4563_CR36","doi-asserted-by":"crossref","first-page":"1426855","DOI":"10.3389\/fnut.2024.1426855","volume":"11","author":"L Jiang","year":"2024","unstructured":"Jiang L, Wang Z, Yuan M et al (2024) Sarcopenia is associated with increased major adverse cardiovascular event incidence in maintenance hemodialysis patients: a prospective cohort study and mediation analysis. Front Nutr 11:1426855","journal-title":"Front Nutr"},{"issue":"2","key":"4563_CR37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jcsm.12901","volume":"13","author":"CW Li","year":"2022","unstructured":"Li CW, Yu K, Shyh-Chang N et al (2022) Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle 13(2):781\u2013794","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"06","key":"4563_CR38","first-page":"15","volume":"22","author":"Q Hongju","year":"2023","unstructured":"Hongju Q, Yandan N, Xiaomei Z et al (2023) Construction of risk prediction model for sarcopenia in patients on maintenance hemodialysis. Mod Clin Nurs 22(06):15\u201321","journal-title":"Mod Clin Nurs"},{"issue":"6","key":"4563_CR39","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.21873\/invivo.12595","volume":"35","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Asai A, Fukunishi S et al (2021) Screening tools for sarcopenia. In Vivo 35(6):3001\u20133009","journal-title":"In Vivo"},{"issue":"3","key":"4563_CR40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P et al (2020) Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21(3):300\u20137.e2","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"4563_CR41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12603-019-1222-x","volume":"23","author":"N Kurita","year":"2019","unstructured":"Kurita N, Wakita T, Kamitani T et al (2019) SARC-F validation and SARC-F+EBM derivation in musculoskeletal disease: the SPSS-OK study. J Nutr Health Aging 23(8):732\u2013738","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"4563_CR42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40520-021-01998-6","volume":"34","author":"T Erdogan","year":"2022","unstructured":"Erdogan T, Catikkas NM, Oren MM et al (2022) Ishii test for screening sarcopenia: performance in community-dwelling older adults. Aging Clin Exp Res 34(4):785\u2013791","journal-title":"Aging Clin Exp Res"},{"key":"4563_CR43","doi-asserted-by":"crossref","unstructured":"Hax V, do Esp\u00edrito Santo RC, Dos Santos LP et al (2021) Practical screening tools for sarcopenia in patients with systemic sclerosis. PLoS One 16(1):e0245683","DOI":"10.1371\/journal.pone.0245683"},{"issue":"1","key":"4563_CR44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s12877-022-03441-5","volume":"22","author":"G Bramato","year":"2022","unstructured":"Bramato G, Barone R, Barulli MR et al (2022) Sarcopenia screening in elderly with Alzheimer\u2019s disease: performances of the SARC-F-3 and MSRA-5 questionnaires. BMC Geriatr 22(1):761","journal-title":"BMC Geriatr"},{"issue":"10","key":"4563_CR45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s12603-020-1445-x","volume":"24","author":"R Li","year":"2020","unstructured":"Li R, Hu X, Tan L et al (2020) Screening for sarcopenia with a Self-Reported Cartoon Questionnaire: combining SARC-F with Finger-Ring Test. J Nutr Health Aging 24(10):1100\u20131106","journal-title":"J Nutr Health Aging"},{"issue":"8","key":"4563_CR46","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jamda.2023.04.005","volume":"24","author":"MH Oh","year":"2023","unstructured":"Oh MH, Shin HE, Kim KS et al (2023) Combinations of sarcopenia diagnostic criteria by Asian Working Group of Sarcopenia (AWGS) 2019 guideline and incident adverse health outcomes in community-dwelling older adults. J Am Med Dir Assoc 24(8):1185\u20131192","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"4563_CR47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3348\/kjr.2018.0479","volume":"20","author":"K Lee","year":"2019","unstructured":"Lee K, Shin Y, Huh J et al (2019) Recent issues on body composition imaging for sarcopenia evaluation. Korean J Radiol 20(2):205\u2013217","journal-title":"Korean J Radiol"},{"issue":"3","key":"4563_CR48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MNH.0000000000000318","volume":"26","author":"RN Moorthi","year":"2017","unstructured":"Moorthi RN, Avin KG (2017) Clinical relevance of sarcopenia in chronic kidney disease. Curr Opin Nephrol Hypertens 26(3):219\u2013228","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"4563_CR49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.jrn.2018.05.002","volume":"28","author":"G Ant\u00f3n-P\u00e9rez","year":"2018","unstructured":"Ant\u00f3n-P\u00e9rez G, Santana-Del-Pino \u00c1, Henr\u00edquez-Palop F et al (2018) Diagnostic usefulness of the protein energy wasting score in prevalent hemodialysis patients. J Ren Nutr 28(6):428\u2013434","journal-title":"J Ren Nutr"},{"issue":"6","key":"4563_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.jrn.2018.04.002","volume":"28","author":"BT Lodebo","year":"2018","unstructured":"Lodebo BT, Shah A, Kopple JD (2018) Is it important to prevent and treat protein-energy wasting in chronic kidney disease and chronic dialysis patients? J Ren Nutr 28(6):369\u2013379","journal-title":"J Ren Nutr"},{"issue":"4","key":"4563_CR51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.mayocp.2015.01.013","volume":"90","author":"P Kokkinos","year":"2015","unstructured":"Kokkinos P, Faselis C, Myers J et al (2015) Exercise capacity and risk of chronic kidney disease in US veterans: a cohort study. Mayo Clin Proc 90(4):461\u2013468","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"4563_CR52","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.3390\/nu13124499","volume":"13","author":"SK Papadopoulou","year":"2021","unstructured":"Papadopoulou SK, Papadimitriou K, Voulgaridou G et al (2021) Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia: a narrative review. Nutrients 13(12):4499","journal-title":"Nutrients"},{"issue":"4","key":"4563_CR53","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00198-019-04908-9","volume":"30","author":"L Pasqualini","year":"2019","unstructured":"Pasqualini L, Ministrini S, Lombardini R et al (2019) Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass. Osteoporos Int 30(4):797\u2013806","journal-title":"Osteoporos Int"},{"issue":"1","key":"4563_CR54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13102-024-00876-8","volume":"16","author":"J Yin","year":"2024","unstructured":"Yin J, Zhang X, Wang Z et al (2024) Application of exercise therapy in patients with chronic kidney disease-induced muscle atrophy: a scoping review. BMC Sports Sci Med Rehabil 16(1):100","journal-title":"BMC Sports Sci Med Rehabil"},{"issue":"4","key":"4563_CR55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40620-018-00565-z","volume":"32","author":"N Salhab","year":"2019","unstructured":"Salhab N, Karavetian M, Kooman J et al (2019) Effects of intradialytic aerobic exercise on hemodialysis patients: a systematic review and meta-analysis. J Nephrol 32(4):549\u2013566","journal-title":"J Nephrol"},{"issue":"2","key":"4563_CR56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00198-017-4339-y","volume":"29","author":"A Varahra","year":"2018","unstructured":"Varahra A, Rodrigues IB, MacDermid JC et al (2018) Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis. Osteoporos Int 29(2):265\u2013286","journal-title":"Osteoporos Int"},{"issue":"09","key":"4563_CR57","first-page":"188","volume":"14","author":"T He","year":"2019","unstructured":"He T, Mai H, Junhua L et al (2019) Observation of the application effect of exercise rehabilitation therapy on patients with uremic sarcopenia. China Pract Med 14(09):188\u2013190","journal-title":"China Pract Med"},{"issue":"1","key":"4563_CR58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jcsm.12874","volume":"13","author":"RH Cha","year":"2022","unstructured":"Cha RH, Kang SH, Han MY et al (2022) Effects of AST-120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study. J Cachexia Sarcopenia Muscle 13(1):397\u2013408","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"4563_CR59","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcsm.12202","volume":"8","author":"Y Enoki","year":"2017","unstructured":"Enoki Y, Watanabe H, Arake R et al (2017) Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction. J Cachexia Sarcopenia Muscle 8(5):735\u2013747","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"4563_CR60","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/cells9122657","volume":"9","author":"E Rybalka","year":"2020","unstructured":"Rybalka E, Timpani CA, Debruin DA et al (2020) The failed clinical story of myostatin inhibitors against duchenne muscular dystrophy: exploring the biology behind the battle. Cells 9(12):2657","journal-title":"Cells"},{"issue":"4","key":"4563_CR61","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/10915818211025477","volume":"40","author":"BT Welsh","year":"2021","unstructured":"Welsh BT, Cote SM, Meshulam D et al (2021) Preclinical safety assessment and toxicokinetics of apitegromab, an antibody targeting proforms of myostatin for the treatment of muscle-atrophying disease. Int J Toxicol 40(4):322\u2013336","journal-title":"Int J Toxicol"},{"issue":"6","key":"4563_CR62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/mus.26113","volume":"57","author":"CE Glasser","year":"2018","unstructured":"Glasser CE, Gartner MR, Wilson D et al (2018) Locally acting ACE-083 increases muscle volume in healthy volunteers. Muscle Nerve 57(6):921\u2013926","journal-title":"Muscle Nerve"},{"issue":"1","key":"4563_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/mus.27558","volume":"66","author":"JM Statland","year":"2022","unstructured":"Statland JM, Campbell C, Desai U et al (2022) Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy. Muscle Nerve 66(1):50\u201362","journal-title":"Muscle Nerve"},{"issue":"1","key":"4563_CR64","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/s41598-021-81669-8","volume":"11","author":"H Muramatsu","year":"2021","unstructured":"Muramatsu H, Kuramochi T, Katada H et al (2021) Novel myostatin-specific antibody enhances muscle strength in muscle disease models. Sci Rep 11(1):2160","journal-title":"Sci Rep"},{"issue":"9","key":"4563_CR65","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","volume":"65","author":"D Rooks","year":"2017","unstructured":"Rooks D, Praestgaard J, Hariry S et al (2017) Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study. J Am Geriatr Soc 65(9):1988\u20131995","journal-title":"J Am Geriatr Soc"},{"key":"4563_CR66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116552","volume":"229","author":"W Parichatikanond","year":"2024","unstructured":"Parichatikanond W, Pandey S, Mangmool S (2024) Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: potential role of GLP-1 receptor and mTOR signaling. Biochem Pharmacol 229:116552","journal-title":"Biochem Pharmacol"},{"key":"4563_CR67","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100979","volume":"37","author":"M Villumsen","year":"2021","unstructured":"Villumsen M, Schelde AB, Jimenez-Solem E et al (2021) GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine 37:100979","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4563_CR68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/endrev\/bnac018","volume":"44","author":"JM Yabut","year":"2023","unstructured":"Yabut JM, Drucker DJ (2023) Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease. Endocr Rev 44(1):14\u201332","journal-title":"Endocr Rev"},{"issue":"2","key":"4563_CR69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcsm.12162","volume":"8","author":"R Yu","year":"2017","unstructured":"Yu R, Chen JA, Xu J et al (2017) Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease. J Cachexia Sarcopenia Muscle 8(2):327\u2013341","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"4563_CR70","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcsm.12434","volume":"10","author":"Y Hong","year":"2019","unstructured":"Hong Y, Lee JH, Jeong KW et al (2019) Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. J Cachexia Sarcopenia Muscle 10(4):903\u2013918","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4563_CR71","doi-asserted-by":"crossref","unstructured":"Morita T, Hayashi K (2022) Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma. Elife 11","DOI":"10.7554\/eLife.77746"},{"key":"4563_CR72","doi-asserted-by":"crossref","first-page":"1342344","DOI":"10.3389\/fmed.2024.1342344","volume":"11","author":"Y Shen","year":"2024","unstructured":"Shen Y, Su X, Yu Z et al (2024) Association between sarcopenic obesity and mortality in patients on peritoneal dialysis: a prospective cohort study. Front Med (Lausanne) 11:1342344","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"4563_CR73","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s40620-022-01283-3","volume":"35","author":"JD Lima","year":"2022","unstructured":"Lima JD, Guedes M, Rodrigues SD et al (2022) High-volume hemodiafiltration decreases the pre-dialysis concentrations of indoxyl sulfate and p-cresyl sulfate compared to hemodialysis: a post-hoc analysis from the HDFit randomized controlled trial. J Nephrol 35(5):1449\u20131456","journal-title":"J Nephrol"},{"issue":"8","key":"4563_CR74","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11255-020-02489-9","volume":"52","author":"H Schiffl","year":"2020","unstructured":"Schiffl H (2020) High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode. Int Urol Nephrol 52(8):1501\u20131506","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"4563_CR75","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJMoa2304820","volume":"389","author":"PJ Blankestijn","year":"2023","unstructured":"Blankestijn PJ, Vernooij RWM, Hockham C et al (2023) Effect of hemodiafiltration or hemodialysis on mortality in kidney failure. N Engl J Med 389(8):700\u2013709","journal-title":"N Engl J Med"},{"issue":"4","key":"4563_CR76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/toxins14040263","volume":"14","author":"S Todoriki","year":"2022","unstructured":"Todoriki S, Hosoda Y, Yamamoto T et al (2022) Methylglyoxal induces inflammation, metabolic modulation and oxidative stress in myoblast cells. Toxins (Basel) 14(4):263","journal-title":"Toxins (Basel)"},{"issue":"1","key":"4563_CR77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40659-023-00431-8","volume":"56","author":"J Orozco-Aguilar","year":"2023","unstructured":"Orozco-Aguilar J, Tacchi F, Aguirre F et al (2023) Ursodeoxycholic acid induces sarcopenia associated with decreased protein synthesis and autophagic flux. Biol Res 56(1):28","journal-title":"Biol Res"},{"issue":"40","key":"4563_CR78","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.2174\/0929867324666170801095850","volume":"25","author":"TB Waltz","year":"2018","unstructured":"Waltz TB, Fivenson EM, Morevati M et al (2018) Sarcopenia, aging and prospective interventional strategies. Curr Med Chem 25(40):5588\u20135596","journal-title":"Curr Med Chem"},{"issue":"11","key":"4563_CR79","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/ijms23116047","volume":"23","author":"TC Cheng","year":"2022","unstructured":"Cheng TC, Huang SH, Kao CL et al (2022) Muscle wasting in chronic kidney disease: mechanism and clinical implications-a narrative review. Int J Mol Sci 23(11):6047","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4563_CR80","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/jcsm.12744","volume":"12","author":"WW Cheung","year":"2021","unstructured":"Cheung WW, Hao S, Zheng R et al (2021) Targeting interleukin-1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis. J Cachexia Sarcopenia Muscle 12(5):1296\u20131311","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"4563_CR81","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1038\/s41598-021-88438-7","volume":"11","author":"T Higashihara","year":"2021","unstructured":"Higashihara T, Nishi H, Takemura K et al (2021) \u03b22-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice. Sci Rep 11(1):9130","journal-title":"Sci Rep"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04563-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04563-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04563-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:09:42Z","timestamp":1761847782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04563-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":81,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4563"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04563-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}